Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

L.A. McKeown

October 10, 2023

News Daily News

Screen for Hypertensive Disorders During Every Prenatal Visit: USPSTF

Michael O'Riordan

September 25, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Conference News ESC 2023

New Lancet Commission Takes Aim at Sudden Cardiac Deaths

Yael L. Maxwell

August 29, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Routine Coronary Tests Prior to Kidney Transplant Questioned

Yael L. Maxwell

January 05, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2022

Caitlin E. Cox

January 02, 2023

Advertisement

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

Screen for Hypertensive Disorders During Every Prenatal Visit: USPSTF

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

New Lancet Commission Takes Aim at Sudden Cardiac Deaths

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

LDL Control Remains Poor in CAD Patients: NHANES

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Routine Coronary Tests Prior to Kidney Transplant Questioned

Top Policy and Practice News for Cardiologists in 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content